Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.745
-0.255 (-5.10%)
At close: Apr 1, 2025, 4:00 PM
4.760
+0.015 (0.32%)
After-hours: Apr 1, 2025, 4:48 PM EDT
Altimmune Employees
Altimmune had 59 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
59
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$339
Profits / Employee
-$1,611,169
Market Cap
365.43M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
ALT News
- 15 days ago - Altimmune: Pemvidutide Differentiation Advancement In MASH Space Continues To Shine - Seeking Alpha
- 18 days ago - Altimmune to test obesity drug for alcohol use disorder and related health conditions - Reuters
- 26 days ago - Altimmune to Host Virtual R&D Day on March 13, 2025 - GlobeNewsWire
- 4 weeks ago - Altimmune to Participate in the Leerink Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Altimmune Q4 Earnings Review: The Big News Is The MASH With Obesity Data Readout Due Q2 - Seeking Alpha
- 4 weeks ago - Altimmune, Inc. (ALT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 5 weeks ago - Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors - GlobeNewsWire